PD-L1 (Programmed Death Ligand 1) as a Marker of Acute Cellular Rejection After Heart Transplantation.,Circulation: Heart Failure

当前位置： X-MOL 学术 › Circ. Heart Fail. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

PD-L1 (Programmed Death Ligand 1) as a Marker of Acute Cellular Rejection After Heart Transplantation.
Circulation: Heart Failure ( IF 9.7 ) Pub Date : 2021-09-24 , DOI: 10.1161/circheartfailure.121.008563
Arrush Choudhary _{1,

2} , D Marshall Brinkley ₁ , Sepideh Besharati ₃ , Wouter C Meijers _{1,

2} , James B Atkinson ₄ , Kaushik Amancherla _{1,

2} , Qingfeng Zhu ₃ , Shi Huang ₅ , Lee S Nguyen _{6,

7,

8} , Joe-Elie Salem _{1,

2,

6,

7} , Enrico Ammirati ₉ , JoAnn Lindenfeld ₁ , Robert A Anders ₃ , Javid Moslehi _{1,

2}

Affiliation

Division of Cardiology (A.C., D.M.B., W.C.M., K.A., J.-E.S., J.L., J.M.), Vanderbilt University Medical Center, Nashville, TN.
Cardio-Oncology Program (A.C., W.C.M., K.A., J.-E.S., J.M.), Vanderbilt University Medical Center, Nashville, TN.
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD (S.B., Q.Z., R.A.A.).
Department of Pathology (J.B.A.), Vanderbilt University Medical Center, Nashville, TN.
Department of Biostatistics (S.H.), Vanderbilt University Medical Center, Nashville, TN.
Department of Pharmacology, Sorbonne University, National Institute of Health and Medical Research, CIC-1901, Public Hospitals of Paris, UNICO-GRECO, Paris, France (L.S.N., J.-E.S.).
Department of Pharmacology, Sorbonne Cardio-Oncology Program, Pitié-Salpêtrière Hospital, Paris, France (L.S.N., J.-E.S.).
Recherche et Innovation, Centres Médico Chirurgicaux Ambroise Paré, Neuilly-sur-Seine, France (L.S.N.).
De Gasperis Cardio Center and Transplant Center, Niguarda Hospital, Milan, Italy (E.A.).